{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:41:51Z","timestamp":1768617711793,"version":"3.49.0"},"reference-count":44,"publisher":"CLOCKSS Archive","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Hum Genet"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0971-6866.120817","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T09:40:25Z","timestamp":1383126025000},"page":"301","source":"Crossref","is-referenced-by-count":8,"title":["Inter and intra ethnic variation of vitamin K epoxide reductase complex and cytochrome P450 4F2 genetic polymorphisms and their prevalence in South Indian population"],"prefix":"10.13030","volume":"19","author":[{"given":"DhakchinamoorthiKrishna","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjanavar","family":"Manjunath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrasekaran","family":"Adithan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DeepakGopal","family":"Shewade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prayaga","family":"Ushakiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangadharan","family":"Reneega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5187","reference":[{"key":"key-10.4103\/0971-6866.120817-1","first-page":"937","volume-title":"The vitamin K-dependent carboxylase","author":"Presnell","year":"2002","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0971-6866.120817-2","first-page":"973","volume-title":"A topological study of the human gamma-glutamyl carboxylase","author":"Tie","year":"2000","journal-title":"Blood"},{"key":"key-10.4103\/0971-6866.120817-3","first-page":"1634","volume-title":"Cloning and expression of the cDNA for human gamma-glutamyl carboxylase","author":"Wu","year":"1991","journal-title":"Science"},{"key":"key-10.4103\/0971-6866.120817-4","first-page":"11032","volume-title":"Vitamin K-dependent carboxylase.Stoichiometry of carboxylation and vitamin K 2,3-epoxide formation","author":"Larson","year":"1981","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0971-6866.120817-5","first-page":"185","volume-title":"VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: Interaction between both genotypes affects dose requirement","author":"Schalekamp","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0971-6866.120817-6","first-page":"565","volume-title":"Pharmacogenetics of oral anticoagulants: A basis for dose individualization","author":"Stehle","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0971-6866.120817-7","first-page":"23","volume-title":"Association of warfarin dose with genes involved in its action and metabolism","author":"Wadelius","year":"2007","journal-title":"Hum Genet"},{"key":"key-10.4103\/0971-6866.120817-8","first-page":"135","volume-title":"Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity","author":"Bodin","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0971-6866.120817-9","first-page":"537","volume-title":"Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2","author":"Rost","year":"2004","journal-title":"Nature"},{"key":"key-10.4103\/0971-6866.120817-10","first-page":"1436","volume-title":"Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans","author":"Bodin","year":"2008","journal-title":"J Thromb Haemost"},{"key":"key-10.4103\/0971-6866.120817-11","first-page":"784","volume-title":"The largest prospective warfarin-treated cohort supports genetic forecasting","author":"Wadelius","year":"2009","journal-title":"Blood"},{"key":"key-10.4103\/0971-6866.120817-12","first-page":"2285","volume-title":"Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose","author":"Rieder","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-6866.120817-13","first-page":"130","volume-title":"Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients","author":"Singh","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"key-10.4103\/0971-6866.120817-14","first-page":"4106","volume-title":"CYP4F2 genetic variant alters required warfarin dose","author":"Caldwell","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/0971-6866.120817-15","first-page":"e1000433","volume-title":"A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose","author":"Takeuchi","year":"2009","journal-title":"PLoS Genet"},{"key":"key-10.4103\/0971-6866.120817-16","first-page":"1337","volume-title":"CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant","author":"McDonald","year":"2009","journal-title":"Mol Pharmacol"},{"key":"key-10.4103\/0971-6866.120817-17","first-page":"489","volume-title":"Reconstructing Indian population history","author":"Reich","year":"2009","journal-title":"Nature"},{"key":"key-10.4103\/0971-6866.120817-18","first-page":"494","volume-title":"Genetic polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population in India","author":"Abraham","year":"2000","journal-title":"Acta Pharmacol Sin"},{"key":"key-10.4103\/0971-6866.120817-19","first-page":"1655","volume-title":"CYP2D6 genetic polymorphism in South Indian populations","author":"Naveen","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"key-10.4103\/0971-6866.120817-20","first-page":"101","volume-title":"CYP2C9 and CYP2C19 genetic polymorphisms: Frequencies in the south Indian population","author":"Jose","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"key-10.4103\/0971-6866.120817-21","first-page":"407","volume-title":"Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population","author":"Arun","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"key-10.4103\/0971-6866.120817-22","first-page":"295","volume-title":"Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population","author":"Krishnakumar","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"key-10.4103\/0971-6866.120817-23","first-page":"6343","volume-title":"Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population","author":"Umamaheswaran","year":"2012","journal-title":"Mol Biol Rep"},{"key":"key-10.4103\/0971-6866.120817-24","first-page":"263","volume-title":"Haploview: Analysis and visualization of LD and haplotype maps","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"key-10.4103\/0971-6866.120817-25","first-page":"1299","volume-title":"A haplotype map of human genome","author":"Altshuler","year":"2005","journal-title":"Nature"},{"key":"key-10.4103\/0971-6866.120817-26","first-page":"677","volume-title":"Linkage disequilibrium patterns vary substantially among populations","author":"Sawyer","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"key-10.4103\/0971-6866.120817-27","first-page":"775","volume-title":"Genetic modulation of oral anticoagulation with warfarin","author":"Margaglione","year":"2000","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0971-6866.120817-28","first-page":"1690","volume-title":"Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy","author":"Higashi","year":"2002","journal-title":"JAMA"},{"key":"key-10.4103\/0971-6866.120817-29","first-page":"429","volume-title":"Genetic analysis of the human cytochrome P450 CYP2C9 locus","author":"Stubbins","year":"1996","journal-title":"Pharmacogenetics"},{"key":"key-10.4103\/0971-6866.120817-30","first-page":"781","volume-title":"Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups","author":"Scott","year":"2010","journal-title":"Pharmacogenomics"},{"key":"key-10.4103\/0971-6866.120817-31","first-page":"687","volume-title":"Association of Vitamin K epoxide reductase complex1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population","author":"Veenstra","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"key-10.4103\/0971-6866.120817-32","first-page":"11","volume-title":"Warfarin dosing and the promise of pharmacogenomics","author":"Dumas","year":"2007","journal-title":"Curr Clin Pharmacol"},{"key":"key-10.4103\/0971-6866.120817-33","first-page":"120","volume-title":"Impact of CYP2C9FNx013, VKORC1-1639, CYP4F2 rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients","author":"Liang","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"key-10.4103\/0971-6866.120817-34","first-page":"517","volume-title":"Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: Proposal for a new dosing regimen","author":"El","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"key-10.4103\/0971-6866.120817-35","first-page":"676","volume-title":"Interactions of warfarin with drugs and food","author":"Wells","year":"1994","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0971-6866.120817-36","first-page":"260","volume-title":"Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients","author":"Lal","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0971-6866.120817-37","first-page":"2563","volume-title":"Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/0971-6866.120817-38","first-page":"306","volume-title":"Optimization of warfarin dose by population-specific pharmacogenomic algorithm","author":"Pavani","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"key-10.4103\/0971-6866.120817-39","doi-asserted-by":"crossref","unstructured":"Gage BF, Lesko LJ. Pharmacogenetics of warfarin: Regulatory, scientific, and clinical issues. J Thromb Thrombolysis 2008;25:45-51.","DOI":"10.1007\/s11239-007-0104-y"},{"key":"key-10.4103\/0971-6866.120817-40","first-page":"753","volume-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","author":"International","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-6866.120817-41","doi-asserted-by":"crossref","unstructured":"Perini JA, Struchiner CJ, Silva-Assun\u00e7\u00e3o E, Santana IS, Rangel F, Ojopi EB, et al. Pharmacogenetics of warfarin: Development of a dosing algorithm for brazilian patients. Clin Pharmacol Ther 2008;84:722-8.","DOI":"10.1038\/clpt.2008.166"},{"key":"key-10.4103\/0971-6866.120817-42","first-page":"2329","volume-title":"The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen","author":"Sconce","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0971-6866.120817-43","first-page":"332","volume-title":"Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans","author":"Schelleman","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0971-6866.120817-44","first-page":"1199","volume-title":"Estimation of warfarin maintenance dose based on VKORC1 (\u22121639 G>A) and CYP2C9 genotypes","author":"Zhu","year":"2007","journal-title":"Clin Chem"}],"container-title":["Indian Journal of Human Genetics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T14:50:05Z","timestamp":1586271005000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijhg.com\/text.asp?2013\/19\/3\/301\/120817"},"secondary":[{"URL":"http:\/\/triggered.stanford.clockss.org\/ServeContent?url=http%3A%2F%2Fwww.ijhg.com%2Farticle.asp%3Fissn%3D0971-6866%3Byear%3D2013%3Bvolume%3D19%3Bissue%3D3%3Bspage%3D301%3Bepage%3D310%3Baulast%3DKumar","label":"CLOCKSS_SU"},{"URL":"http:\/\/triggered.edina.clockss.org\/ServeContent?url=http%3A%2F%2Fwww.ijhg.com%2Farticle.asp%3Fissn%3D0971-6866%3Byear%3D2013%3Bvolume%3D19%3Bissue%3D3%3Bspage%3D301%3Bepage%3D310%3Baulast%3DKumar","label":"CLOCKSS_EDINA"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"alternative-id":["120817"],"URL":"https:\/\/doi.org\/10.4103\/0971-6866.120817","relation":{},"ISSN":["0971-6866"],"issn-type":[{"value":"0971-6866","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}